Surgery

Muneera Kapadia, MD

Portrait

Colorectal Surgeon
General Surgery Residency Associate Program Director
Clinical Assistant Professor of Surgery  - Gastrointestinal, Minimally-invasive and Bariatric Surgery

Contact Information

Primary Office: 4605 JCP
Iowa City, IA 52242
Primary Office Phone: 319-384-7359

Email: muneera-kapadia@uiowa.edu

Education

MD, University of Michigan Medical School
BS, Chemical Engineering, Massachusetts Institute of Technology, Boston, MA

Intern, General Surgery, McGaw Med Center, Northwestern University, Chicago, IL
Residency, General Surgery, McGaw Medical Center, Northwestern University
Fellowship, Colorectal Surgery, University of Minnesota

Licensure and Certifications

Iowa Medical License (Permanent), Iowa Board of Medicine
Board Certified, American Board of Colon and Rectal Surgeons
Board Certified, General Surgery, American Board of Surgery
Certified, Advanced Trauma Life Support

All Publications

Lorenzon A, Sherman S, Rosenbaum M, Kapadia M.  Resident involvement in postoperative conversations: an underused opportunity.  J Surg Res.  2014 August. 190(2):437-44.
[PubMed]

Hrabe J, Byrn J, Button A, Zamba G, Kapadia M, Mezhir J.  A matched case-control study of IBD-associated colorectal cancer: IBD protends worse outcome.  J Surg Oncol.  2014 February. 109(2):117-21.
[PubMed]

Tsihlis N, Kapadia M, Vavra A, Flannery W, Oustwani C, Jiang Q, Kibbe M.  Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature. .  Journal of Vascular Surgery.  2013 July. 58(1):179-86.
[PubMed]

Hrabe J, Kapadia M, Zamba G, Byrn J, Mezhir J.  An Evaluation of Patients with Inflammatory Bowel Disease who Develop Colorectal Cancer.  2013 February. 

Hrabe J, Chong H, Mezhir J, Kapadia M.  Outcomes and Complications Associated with Hernia Repair in Patients with Inflammatory Bowel Disease.  2013 February. 

Tsihlis N, Kapadia M, Vavra A, Jiang Q, Fu B, Martinez J, Kibbe M.  Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature.  Nitric Oxide: Biology and Chemistry / Official Journal of the Nitric Oxide Society.  2012 June 30. 27(1):50-8.
[PubMed]

Kapadia M, Kreiter C, Healy M.  Resident Performance is Reliably Evaluated by Surgery Faculty.  2012 April. 

Kapadia M, Lowry A.  Ischemic Colitis.  2012. 

Tsihlis N, Murar J, Kapadia M, Ahanchi S, Oustwani C, Saavedra J, Keefer L, Kibbe M.  Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.  Journal of Vascular Surgery.  2010 May. 51(5):1248-59.
[PubMed]

Kibbe M, Martinez J, Popowich D, Kapadia M, Ahanchi S, Aalami O, Jiang Q, Webb A, Yang J, Carroll T, Ameer G.  Citric acid-based elastomers provide a biocompatible interface for vascular grafts.  Journal of Biomedical Materials Research, Part A.  2010 April. 93(1):314-24.
[PubMed]

Kapadia M, Eng J, Jiang Q, Stoyanovsky D, Kibbe M.  Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells.  Nitric Oxide: Biology and Chemistry / Official Journal of the Nitric Oxide Society .  2009 June. 20(4):279-88.
[PubMed]

Kapadia M, de Hoyos A, Blum M.  Acute superior vena cava occlusion after stenting of tracheoesophageal fistula.  The Annals of Thoracic Surgery.  2009 April. 87(4):1260-2.
[PubMed]

Ahanchi S, Varu V, Tsihlis N, Martinez J, Pearce C, Kapadia M, Jiang Q, Saavedra J, Keefer L, Hrabie J, Kibbe M.  Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.  American Journal of Physiology, Heart and Circulatory Physiology.  2008 December. 295(6):H2388-98.
[PubMed]

Kapadia M, Aalami O, Najjar S, Jiang Q, Muar J, Lyle B, Eng J, Kane B, Carroll T, Cahill P, Kibbe M.  A reproducible porcine ePTFE arterial bypass model for neointimal hyperplasia. .  The Journal of Surgical Research.  2008 August. 148(2):230-7.
[Link]

Kapadia M, Melstrom L, Halverson A.  Presentation and treatment outcomes of anal condyloma.  2008 June. 

Kapadia M, Popowich D, Kibbe M.  Modified prosthetic vascular conduits.  Circulation.  2008 April 8. 117(14):1873-82.
[PubMed]

Kapadia M, Melstrom L, Bentrem D, Halverson A.  Anal human papilloma virus and dysplasia in HIV-negative women. .  2008 March. 

Tsihlis N, Murar J, Flannery W, Kapadia M, Ahanchi S, Martinez J, Jiang Q, Popowich D, Saavedra J, Keefer L, Kibbe M.  The diazeniumdiolate IPA/NO moderates neointimal hyperplasia following vascular interventions via a mechanism distinct from nitric oxide. .  2008 February. 

Angelos P, Kapadia M.  Physicians and cancer patients: communication and advance directives. .  Cancer Treatment and Research.  2008. 140:13-28.
[PubMed]

Kapadia M, Eng J, Murar J, Jiang Q, Kibbe M.  26S proteasome: intracellular localization and regulation by nitric oxide.  2007 November. 

Pearce C, Najjar S, Kapadia M, Muar J, Eng J, Lyle B, Aalami O, Jiang Q, Hrabie J, Saavedra J, Keefer L, Kibbe M.  Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. .  Free Radical Biology and Medicine.  2007 September 25. 44(1):73-81.
[Link]

Kapadia M, DaRosa D, MacRae H, Dunnington G.  Current assessment and future directions of surgical skills laboratories. .  Journal of Surgical Education.  2007 September. 64(5):260-5.
[Link]

Kapadia M, Chow L, Tsihlis N, Ahanchi S, Eng J, Murar J, Martinez J, Popowich D, Jiang Q, Hrabie J, Saavedra J, Keefer L, Hulvat J, Stupp S, Kibbe M.  Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. .  2007 June. 

Ahanchi S, Pearce C, Kapadia M, Tsihlis N, Jiang Q, Martinez J, Saavedra J, Keefer L, Kibbe M.  Heightened efficacy of nitric oxide in diabetes and metabolic syndrome following arterial injury..  2007 May. 

Ahanchi S, Pearce C, Kapadia M, Jiang Q, Martinez J, Saavedra J, Keefer L, Kibbe M.  Improved efficacy of a nitric oxide-eluting therapy in diabetes.  2007 April. 

Kapadia M, DaRosa D, MacRae H, Dunnington G.  Survey of surgical skills laboratory..  2007 April. 

Kapadia M, Flannery W, Rossi N, Jiang Q, Kibbe M.  Nitric oxide inhibits de-ubiquitination by isopeptidase T. .  2007 February. 

Kapadia M, Chow L, Tsihlis N, Ahanchi S, Eng J, Muar J, Martinez J, Popowich D, Jiang Q, Hrabie J, Saavedra J, Keefer L, Hulvat J, Stupp S, Kibbe M.  Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. .  Journal of Vascular Surgery.  2007. 47(1):173-82.
[Link]

Yang J, Motlagh D, Allen J, Webb A, Kibbe M, Aalami O, Kapadia M, Carroll T, Ameer G.  Improving the biocompatibility of expanded polytetrafluoroethylene vascular graft via a novel biodegradable elastomer. .  2006 November. 

Kapadia M, Aalami O, Jiang Q, Elhofy A, Kibbe M.  Nitric inhibits the 26S proteasome in six cell types important in the vasculature. .  2006 October. 

Yang J, Motlagh D, Allen J, Webb A, Kibbe M, Aalami O, Kapadia M, Carroll T, Ameer G.  Poly-(diol citrate)-mediated functionalization of ePTFE grafts.  2006 October. 

Kapadia M, Aalami O, Jiang Q, Kibbe M.  The role of nitric oxide in regulating caspase-like activity of the 26S proteasome. .  2006 June. 

Aalami O, Kapadia M, Jiang Q, Kibbe M.  The role of p53, nitric oxide and reactive oxygen species in vascular smooth muscle cell apoptosis..  2006 June. 

Aalami O, Kapadia M, Najjar S, Jiang Q, Zuckerbraun B, Kibbe M.  The role of p53 and heme oxygenase in regulating nitric oxide-induced apoptosis of vascular smooth muscle cells. .  2006 March. 

Pearce C, Najjar S, Kapadia M, Murar J, Eng J, Lyle B, Aalami O, Jiang Q, Hrabie J, Saavedra J, Keefer L, Kibbe M.  Efficacy of perivascular NO-eluting therapies for the prevention of neointimal hyperplasia. .  2006 February. 

Kapadia M, Aalami O, Najjar S, Jiang Q, Kibbe M.  Nitric oxide-mediated inhibition of the PA28 proteasome activator. .  2006 February. 

Kapadia M, Popowich D, Kibbe M.  Modified prosthetic vascular conduits.  2006. 

Yang J, Motlagh D, Allen J, Webb A, Kibbe M, Aalami O, Kapadia M, Carroll T, Ameer A.  Modulating Expanded Polytetrafluoroethylene Vascular Graft Host Response via Citric Acid‐Based Biodegradable Elastomers .  Advanced Materials.  2006. 18:1493-8.
[Link]

Kapadia M, Aalami O, Jiang Q, Kibbe M.  Nitric oxide reversibly inhibits the PA28 activator via S-nitrosylation .  Poster at the Society for Free Radical Biology and Medicine Meeting.  2005 November. 

Kapadia M, Najjar S, Kibbe M.  Nitric oxide-based therapies in Vascular Disease.  2005. 

Date Last Modified: 06/07/2014 - 21:56:23